PLEASANTON, Calif., May 11, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will host an analyst day in New York, New York on Thursday, June 22, 2017. The meeting will be held at the Sofitel New York Hotel.
Members of Natus Medical’s management team will host a series of presentations beginning at 9:00 a.m. Eastern Time. A live webcast of the event will be available at http://investor.natus.com and an archive will also be available. Space for the event is limited and pre-registration is required. For additional information on the event, please contact Natus investor relations at [email protected].
About Natus Medical Incorporated
Natus is a leading provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President and Chief Financial Officer (925) 223-6700 [email protected]


Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions 



